title: The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes.
abstract: Thirteen neuropeptide Y (NPY) agonists were administered intracerebroventricularly (i.c.v.) in rats (full dose-response curves) to estimate their half-effective dose (ED50) on feeding. These values were compared to their binding affinities (IC50) for rat NPY receptor subtypes Y1, Y2, Y4 and Y5 in vitro. Correlations between in vivo ED50 and in vitro IC50 were strong for the Y5 (r = 0.87; P < 0.01), weak for the Y1 (r = 0.48; P < 0.04) and non-significant for the Y2 and Y4 receptor subtypes. In vitro, h[D-Trp32]NPY was found to be a Y5-selective ligand and a full agonist in Y5-expressing cells. In vivo, it dose-dependently stimulated feeding, but failed to induce the full maximal response observed with pNPY. It did not antagonize pNPY-induced feeding and overfeeding in 24 h fasted rats. These findings demonstrate a role for the Y5, or possibly Y5 in combination with Y1, but not Y2 or Y4 receptor subtypes in feeding. No evidence was found for the existence of an additional, as yet undescribed, NPY feeding receptor.
authors.affiliation: Metabolic and Cardiovascular Diseases, Novartis Pharma AG, Basle, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Wyss
authors.forename: A
authors.initials: A
authors.lastname: Stricker-Krongrad
authors.forename: L
authors.initials: L
authors.lastname: Brunner
authors.forename: J
authors.initials: J
authors.lastname: Miller
authors.forename: A
authors.initials: A
authors.lastname: Crossthwaite
authors.forename: S
authors.initials: S
authors.lastname: Whitebread
authors.forename: L
authors.initials: L
authors.lastname: Criscione
mesh_terms: D000818:Animals; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects* / Q000502:physiology*; D005508:Food Deprivation / Q000502:physiology; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D009478:Neuropeptide Y / Q000008:administration & dosage / Q000819:agonists* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017476:Receptors, Neuropeptide Y / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000502:physiology*; D014162:Transfection
chemical_list: D009478:Neuropeptide Y; D017476:Receptors, Neuropeptide Y; C097212:neuropeptide Y-Y1 receptor; C095889:neuropeptide Y2 receptor; C100568:neuropeptide Y5 receptor; C109491:neuropeptide Y4 receptor